And if it wasn't price sensitive, the ASX would have overridden (especially considering how often IMU releases announcements)
As you literally said yourself, it is still up to the ASX to assess whether or not an announcement is important or fluff. The company can't just write something up and call it price sensitive
Ann: Imugene and NeoImmuneTech to Improve Cancer Treatments, page-19
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.003(5.08%) |
Mkt cap ! $435.5M | |||
| Open | High | Low | Value | Volume |
| 6.0¢ | 6.1¢ | 5.5¢ | $1.909M | 33.33M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 1376822 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 313857 | 4 |
View Market Depth
| Last trade - 12.51pm 24/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |